Abnormalities in aldosterone secretion are unusual in Cushing's syndrome even in the presence of hypokalemic alkalosis (1). Similarly, increased cortisol excretion is not seen in primary aldosteronism (2-7). Little information regarding corticosterone secretion is available in either condition. Increased excretion of corticosterone metabolites has been suggested in several cases of primary aldosteronism (8, 9) . The concentration of aldosterone and frequently of corticosterone is increased in primary aldosteronism tumor tissue (10-13). Cortisol content in adrenal tissue of patients with Cushing's syndrome is not increased (10, 12, 14) , nor does the rate of production in vitro increase, although total production by the entire hyperplastic gland or adenoma is greater than in normal tissue (15).
(Submitted for publication September 6, 1962 ; accepted December 20, 1962) Abnormalities in aldosterone secretion are unusual in Cushing's syndrome even in the presence of hypokalemic alkalosis (1) . Similarly, increased cortisol excretion is not seen in primary aldosteronism (2) (3) (4) (5) (6) (7) . Little information regarding corticosterone secretion is available in either condition. Increased excretion of corticosterone metabolites has been suggested in several cases of primary aldosteronism (8, 9) . The concentration of aldosterone and frequently of corticosterone is increased in primary aldosteronism tumor tissue (10) (11) (12) (13) . Cortisol content in adrenal tissue of patients with Cushing's syndrome is not increased (10, 12, 14) , nor does the rate of production in vitro increase, although total production by the entire hyperplastic gland or adenoma is greater than in normal tissue (15) .
We measured secretory rates of cortisol,' corticosterone, and aldosterone in normal subjects, patients with Cushing's syndrome, and patients with primary aldosteronism. In addition, urinary aldosterone was quantitated in seventeen patients with Cushing's syndrome and in two patients who had been on continuous steroid therapy for more than 9 years. The steroid content of the adrenal tumor and the contiguous gland was measured in nine patients with primary aldosteronism. Similar measurements were made in three hyperplastic glands and three adenomas from patients with Cushing's syndrome. Steroid con-1 Names of compounds listed: cortisol = 17-hydroxycorticosterone, corticosterone = 4-pregnene-11j8,21-diol-3, 20 -dione, aldosterone = 11,,21 -dihydroxy -18 -formyl -4 -pregnene-3,20-dione, desoxycorticosterone = 21-hydroxy-4-pregnene-3,20-dione, and 11-desoxycortisol = 17a,21-dihydroxy-4-pregnene-3, 20-dione. centration of the adrenal vein was determined in two patients with Cushing's syndrome and six with primary aldosteronism.
METHODS
Cushing's syndrome. The Priniary aldosteronism (12 patients: 7 males, 5 females). All patients with primary aldosteronism had hypokalemia, hypertension, hypervolemia, increased excretion of urinary aldosterone, and unilateral adenomas were found in eleven. Normal adrenal glands were found in a single patient, K.L., in whom only secretory rates were measured.
Secretory rates of cortisol, corticosterone, and aldosterone. Measurements were made while patients were receiving constant metabolic diets containing more than 110 mEq of sodium. The radioisotopes 2 cortisol-4-C4 (SA 42.4 ,c per mg), corticosterone-4-C"4 (SA 44.2 Ac per mg), and 7-H3-d-aldosterone (SA 20 ,uc per i'g) were purified by paper chromatography and kept in 100% ethanol until use. Secretory rates of cortisol were determined by a modification of the techniques of Cope and Black (16), Peterson (17) , and Flood and co-workers (18); corticosterone was measured by the technique of Peterson (19) and aldosterone by modified techniques of Peterson (17) , and Flood and co-workers (18) . One iec (0.022 mg) of cortisol-4-C4, 1 juc (0.022 mg) of corticosterone-4-C14, and 3 /Ac (0.15 ,ug) of 7-H'-d-aldosterone were added to 20 ml isotonic saline and simultaneously injected intravenously between 8 and 10 a.m. A 24-hour urine specimen was collected. Inulin, or creatinine clearances, or both were normal or high. More than 90% of the in- 2 Radioactive isotopes were gifts of the Endocrinology Study Section, National Institutes of Health, Bethesda, Md.
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jected dose was excreted in the first 24 hours, and total injected radioactivity was used in calculating the secretory rate. The specific activity of a metabolite was determined as follows.
a. Cortisol and corticosterone. A 50-to 100-ml sample was washed with 2 vol ethyl acetate before hydrolysis with Ketodase (#-glucuronidase) at pH 4.8 at 450 C for 18 hours. After incubation, tetrahydrocorticosterone 2 was extracted from the urine by two treatments with 4 vol carbon tetrachloride. The same urine was then treated twice with 2 vol methylene dichloride to extract tetrahydrocortisol and tetrahydrocortisone. The extracts were washed with 5% Na2CO,, then 0.1 N HCl, were dried over anhydrous Na.SO4, filtered, and evaporated to dryness. Each extract was chromatographed on Whatman no. 2 filter paper for 6 hours in an iso-octane: tertiary butanol: water (50: 50: 50 v/v) system. Chromatograms were then scanned for radioactivity with a Vanguard Autoscanner. The radioactive areas were eluted and rechromatographed on Whatman no. 2 paper in a toluene: methanol: water (125: 50: 50 v/v) system, 31/C hours for tetrahydrocorticosterone and 24 hours for tetrahydrocortisol and tetrahydrocortisone. The metabolites were then identified by scanning for radioactivity and were eluted. Specific activity was determined by chemical quantitation with the alkaline blue tetrazolium reaction and by C1' activity in a liquid scintillation spectrometer. The specific activities of tetrahydrocortisol and tetrahydrocortisone were virtually identical.
b. Aldosterone. The specific activity of the 3-oxo conjugate was used to determine the secretory rate of aldosterone. A 100-ml sample was hydrolyzed at pH 1 for 24 hours, extracted with dichloromethane, and dried. After the extract was chromatographed in a cyclohexane: benzene: methanol: water (50: 100: 100:40 v/v) system for 16 hours, the aldosterone was acetylated with C"-acetic anhydride for quantitation, and chromatographed as aldosterone diacetate in 3 different systems by the method described by Kliman and Peterson (20) .
Tissue and adrenal vein content. The adrenal tissue was immediately frozen after removal until extraction could be done. One-half to 1 g adrenal tumor or adrenal gland, and 1 to 2 ml adrenal venous plasma were prepared as previously described (21) , the extracts were acetylated with tritiated acetic anhydride, chromatographed in 3 different systems, and analyzed for steroid content by the double isotope derivative technique using the C"-acetates of cortisol, corticosterone, aldosterone, desoxycorticosterone, and 1 1-desoxycortisol to monitor losses.
The acetylated steroids were extracted with dichloromethane, dried, and chromatographed in a cyclohexane: benzene: methanol: water (100: 25 (Figure 4) showed low normal basal excretion of aldosterone Secretory rates of cortisol, corticosterone, and aldosterone (Table II) . In seven patients, the secretion of cortisol was normal, and in ten, so was the urinary excretion of Porter-Silber chromogens. In three of seven patients, secretion of corticosterone was increased. Secretion of aldosterone was measured in nine patients, and the increases ranged from 300 to 1200 MAg per 24 hours. Urinary excretion was increased in eleven patients 28 to 110 Mug per 24 hours (normal range, 4 to 22
Mug per 24 hours). In two of the patients in whom randomly labeled, tritiated dl-aldosterone was used, the secretory rates were from 600 to 800 jMg per 24 hours; this corresponds to a secretory rate of 300 and 400 Mug per 24 hours of d-aldosterone, since l-aldosterone is not metabolized.
Tissue analysis
Cushing's syndromte (Table III) . In hyperplastic glands, the mean content of cortisol, 11- (Table IV) The mean concentration of cortisol in Cushing's syndrome (hyperplasia) was greater than in primary aldosteronism (mean, 5.5 against 3.3 jMg per ml). Corticosterone concentrations were virtually similar in both Cushing's syndrome and primary aldosteronism. Mean aldosterone concentration was greater in primary aldosteronism than in Cushing's syndrome (mean, 0.53 against 0.05 MAg per ml). In one case, the concentration of aldosterone on the pathologic side showed a slight increase over that of the contralateral adrenal vein. 
DISCUSSION
In our current concepts of the biosynthetic pathways of adrenocortical steroidogenesis, a dichotomy between cortisol and aldosterone synthesis exists. Cushing's syndrome and primary aldosteronism are clinical expressions of the predominance of one pathway or the other.
The secretory rate of cortisol in Cushing's syndrome is well above the normal range. The secretory rate of corticosterone, however, was normal in our patients, with the exception of an elevation in the patient with adrenocortical carcinoma. Secretory rates and urinary excretion of aldosterone were normal, results which agree with those of others (24) (25) (26) , although hypertension was present in 14 of 17 patients and hypokalemia was seen in but one. Two significantly lowered secretory rates were observed, however, one in a patient with adenoma, the other, in one with carcinoma.
Despite the inherent difficulties in interpreting a momentary measurement of concentration in these active pathophysiologic states, the analysis of pathologic tissue in Cushing's syndrome revealed interesting correlations. For this study, we used as normal content of adrenal tissue the ipsilateral adrenal gland of the patients with primary aldosteronism. These glands were all normal in weight, no abnormalities were seen upon histologic study, except for areas of nodular hyperplasia in one patient, and steroid values were similar to those of normal adrenal tissue (10) . In both groups of Cushing's syndrome, hyperplasia and adenoma, cortisol content was not increased, although its secretory rate was, and the content of corticosterone was normal in hyperplasia, but decreased in adenoma. The content of aldosterone was virtually normal in hyperplastic tissue, as well as in the suppressed adrenal gland associated with an adenoma, but was decreased in tumor tissue itself. On analysis, the suppressed adrenal gland was almost devoid of cortisol and corticosterone, but aldosterone, 11-desoxycortisol, and desoxycorticosterone were measurable.
These observations are of particular significance because the suppressed adrenal gland remaining after operation in patient C.G. was able to increase aldosterone secretion after salt restriction without concomitant increase in cortisol secretion; aldosterone excretion increased promptly with ACTH in C.G., whereas excretion of Porter-Silber chromogens was considerably delayed; and four patients with hyperplasia and two with carcinoma were also able to increase aldosterone secretion after salt deprivation. In addition, two patients with profound adrenal suppression due to prolonged corticoid therapy were similarly able to increase aldosterone secretion promptly after the potent stimulus of salt restriction, whereas response in Porter-Silber chromogens and 17-ketosteroids was delayed after ACTH. The second day of ACTH did not increase urinary aldosterone in D.G., but did so in D.V.; apparently, maximal response had been achieved by salt deprivation in D.G. B.P., a patient with adrenal hyperplasia, had normal aldosterone excretion and normal responses to salt deprivation before and after unilateral adrenalectomy. This again shows that in the presence of increased endogenous or exogenous cortisol, aldosterone secretion responds normally. In a further contrast of primary aldosteronism and Cushing's syndrome, mean adrenal vein concentration of cortisol at surgery was higher in Cushing's syndrome than in primary aldosteronism, and conversely, mean concentration of aldosterone was higher in primary aldosteronism than in Cushing's syndrome. Mean corticosterone concentration showed no difference.
These studies in nonmalignant Cushing's syn-drome show that secretion and excretion of aldosterone and secretion of corticosterone are normal in the presence of increased cortisol secretion. The virtual absence of corticosterone and aldosterone in adrenocortical tumors could be interpreted to mean that these tissues are producing predominantly cortisol. There were no marked differences in the 11-desoxycortisol content between the tumors and the glands in either Cushing's syndrome or primary aldosteronism.
Preservation of normal secretory and excretory aldosterone patterns and normal adrenal gland concentration of aldosterone is consistent with the observation that prolonged cortisol administration effects no changes in aldosterone excretion (27, 28) . The site of aldosterone production is not clear in hyperplasia, but in Cushing's syndrome due to adenoma, it may reside in the atrophic adrenal gland.
In primary aldosteronism, increased aldosterone secretion occurred in the presence of normal cortisol secretion, but in two of five patients, increased secretion of corticosterone was observed. In contrast to Cushing's syndrome, mean concentration of corticosterone and aldosterone of eight tumors showed a two-and threefold increase, respectively, over the adjacent adrenal gland. The higher concentrations of corticosterone were associated with higher secretory rates of corticosterone.
The content of aldosterone in tumor tissue was not related to the level of urinary aldosterone or its secretory rate, as previously noted (11) . In every case but one (C.H.), aldosterone content of the adrenocortical tumor was greater than that of the adjacent adrenal gland. The mean difference in concentration in tumor and gland was threefold. Others have reported similar increases in corticosterone and aldosterone (10) (11) (12) (13) .
In vitro incubation of pathologic tissues producing Cushing's syndrome and primary aldosteronism has at times demonstrated the propensity of these tissues to produce cortisol and aldosterone more rapidly than normal tissue (29) . In vivo secretory rates of these studies, however, delineate the secretory patterns more clearly. In contrast to Cushing's syndrome, almost uniform agreement is observed between increased aldosterone content in the tumor and increased secretory rate in primary-aldosteronism.
It is of particular importance that the increased content of corticosterone in tumors producing primary aldosteronism is usually not apparent as increased secretion. This, together with the finding that desoxycorticosterone content in tumors is increased in the same ratio as aldosterone, suggests their participation in the overproduction of aldosterone.
The absence of clear-cut increases of precursor steroids in tissue producing Cushing's syndrome, as compared with tissue giving rise to primary aldosteronism, is difficult to explain from these studies. The in vivo secretory studies clearly show the differences that exist, especially in the secretion of corticosterone. These studies again demonstrate the independence and preservation of aldosterone secretion in states of excessive endogenous cortisol production or exogenous administration of corticosteroids. SUM 
MARY
In Cushing's syndrome, cortisol secretion was consistently elevated. Corticosterone secretion was normal, except in a single case of malignancy. Aldosterone secretion ranged from normal to low. Analysis of hyperplastic glands showed normal concentrations of cortisol, 11-desoxycortisol, aldosterone, corticosterone, and desoxycorticosterone. Analysis of adenomas revealed normal cortisol content, lowered corticosterone content, and low to absent aldosterone content. The suppressed ipsilateral adrenal gland revealed low cortisol and corticosterone content, but normal amounts of aldosterone, desoxycorticosterone, and 11-desoxycortisol. Patients with Cushing's syndrome had normal urinary aldosterone. The suppressed adrenal tissue remaining in patients who had adenomas surgically removed, as well as that in two patients who had prolonged steroid therapy, was capable of secreting normal amounts of aldosterone.
In primary aldosteronism, cortisol secretion was normal. In three of seven patients, there was an increase in corticosterone secretion. Aldosterone secretion was greatly increased. The tumor's content of cortisol was normal, but there was increased content of corticosterone, desoxycorticosterone, and aldosterone. Normal aldosterone secretion and responses are preserved in the presence of exogenous or endogenous cortisol excess.
